title: Preclinical phase III trials in translational stroke research: call for collective design of framework and guidelines.
authors.affiliation: From the Fraunhofer Institute of Cell Therapy and Immunology and Translational Center of Regenerative Medicine, University of Leipzig, Leipzig, Germany (J.B., D.-C.W.); Neurovascular Research Laboratory, Departments of Neurology and Radiology, Massachusetts General Hospital and Harvard Medical School, Boston (J.B., C.A.); and Institute for Stroke and Dementia Research, University of Munich Medical Center, Munich, Germany (N.P.).
authors.forename: Johannes
authors.initials: J
authors.lastname: Boltze
authors.forename: Cenk
authors.initials: C
authors.lastname: Ayata
authors.forename: Daniel-Christoph
authors.initials: DC
authors.lastname: Wagner
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Plesnila
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000639:trends*; D017408:Guidelines as Topic; D006801:Humans; D012107:Research Design; D012307:Risk Factors; D020521:Stroke / Q000503:physiopathology / Q000628:therapy*; D057170:Translational Research, Biomedical / Q000458:organization & administration* / Q000639:trends
keywords: models, animal; quality assurance, healthcare; quality improvement; translational medical research